Using MCC950 and NLRP3 siRNA, NLRP3 inflammasome and liver fibrosis can be reduced in nonalcoholic steatohepatitis (NASH) and S. japonicum mice, respectively [22, 50]. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.